9
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Serological screening in wild ruminants in Germany, 2021/2022: No evidence of SARS‐CoV‐2, bluetongue virus or pestivirus spread but high seroprevalences against Schmallenberg virus

      brief-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Wildlife animals may be susceptible to multiple infectious agents of public health or veterinary relevance, thereby potentially forming a reservoir that bears the constant risk of re‐introduction into the human or livestock population. Here, we serologically investigated 493 wild ruminant samples collected in the 2021/2022 hunting season in Germany for the presence of antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and four viruses pathogenic to domestic ruminants, namely, the orthobunyavirus Schmallenberg virus (SBV), the reovirus bluetongue virus (BTV) and ruminant pestiviruses like bovine viral diarrhoea virus or border disease virus. The animal species comprised fallow deer, red deer, roe deer, mouflon and wisent. For coronavirus serology, additional 307 fallow, roe and red deer samples collected between 2017 and 2020 at three military training areas were included. While antibodies against SBV could be detected in about 13.6% of the samples collected in 2021/2022, only one fallow deer of unknown age tested positive for anti‐BTV antibodies, and all samples reacted negative for antibodies against ruminant pestiviruses. In an ELISA based on the receptor‐binding domain (RBD) of SARS‐CoV‐2, 25 out of 493 (5.1%) samples collected in autumn and winter 2021/2022 scored positive. This sero‐reactivity could not be confirmed by the highly specific virus neutralisation test, occurred also in 2017, 2018 and 2019, that is, prior to the human SARS‐CoV‐2 pandemic, and was likewise observed against the RBD of the related SARS‐CoV‐1. Therefore, the SARS‐CoV‐2 sero‐reactivity was most likely induced by another hitherto unknown deer virus belonging to the subgenus Sarbecovirus of betacoronaviruses.

          Related collections

          Most cited references44

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          The species Severe acute respiratory syndrome-related coronavirus : classifying 2019-nCoV and naming it SARS-CoV-2

          The present outbreak of a coronavirus-associated acute respiratory disease called coronavirus disease 19 (COVID-19) is the third documented spillover of an animal coronavirus to humans in only two decades that has resulted in a major epidemic. The Coronaviridae Study Group (CSG) of the International Committee on Taxonomy of Viruses, which is responsible for developing the classification of viruses and taxon nomenclature of the family Coronaviridae, has assessed the placement of the human pathogen, tentatively named 2019-nCoV, within the Coronaviridae. Based on phylogeny, taxonomy and established practice, the CSG recognizes this virus as forming a sister clade to the prototype human and bat severe acute respiratory syndrome coronaviruses (SARS-CoVs) of the species Severe acute respiratory syndrome-related coronavirus, and designates it as SARS-CoV-2. In order to facilitate communication, the CSG proposes to use the following naming convention for individual isolates: SARS-CoV-2/host/location/isolate/date. While the full spectrum of clinical manifestations associated with SARS-CoV-2 infections in humans remains to be determined, the independent zoonotic transmission of SARS-CoV and SARS-CoV-2 highlights the need for studying viruses at the species level to complement research focused on individual pathogenic viruses of immediate significance. This will improve our understanding of virus–host interactions in an ever-changing environment and enhance our preparedness for future outbreaks.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

            A new and highly pathogenic coronavirus (severe acute respiratory syndrome coronavirus-2, SARS-CoV-2) caused an outbreak in Wuhan city, Hubei province, China, starting from December 2019 that quickly spread nationwide and to other countries around the world1-3. Here, to better understand the initial step of infection at an atomic level, we determined the crystal structure of the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 bound to the cell receptor ACE2. The overall ACE2-binding mode of the SARS-CoV-2 RBD is nearly identical to that of the SARS-CoV RBD, which also uses ACE2 as the cell receptor4. Structural analysis identified residues in the SARS-CoV-2 RBD that are essential for ACE2 binding, the majority of which either are highly conserved or share similar side chain properties with those in the SARS-CoV RBD. Such similarity in structure and sequence strongly indicate convergent evolution between the SARS-CoV-2 and SARS-CoV RBDs for improved binding to ACE2, although SARS-CoV-2 does not cluster within SARS and SARS-related coronaviruses1-3,5. The epitopes of two SARS-CoV antibodies that target the RBD are also analysed for binding to the SARS-CoV-2 RBD, providing insights into the future identification of cross-reactive antibodies.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

              The serum level of RBD-binding antibodies correlates with SARS-CoV-2 neutralization and can be used for population-level surveillance.
                Bookmark

                Author and article information

                Contributors
                kerstin.wernike@fli.de
                martin.beer@fli.de
                Journal
                Transbound Emerg Dis
                Transbound Emerg Dis
                10.1111/(ISSN)1865-1682
                TBED
                Transboundary and Emerging Diseases
                John Wiley and Sons Inc. (Hoboken )
                1865-1674
                1865-1682
                02 June 2022
                02 June 2022
                : 10.1111/tbed.14600
                Affiliations
                [ 1 ] Friedrich‐Loeffler‐Institut Greifswald–Insel Riems Germany
                [ 2 ] State Agency for Nature, Environment and Consumer Protection North Rhine‐Westphalia Wildlife Research Institute Bonn Germany
                [ 3 ] Chamber of Agriculture for North Rhine‐Westphalia Bovine Health Service Bad Sassendorf Germany
                [ 4 ] Central Institute of the Bundeswehr Medical Service Kiel Kronshagen Germany
                [ 5 ] Landesbetrieb Hessisches Landeslabor Gießen Germany
                [ 6 ] Bavarian Health and Food Safety Authority Oberschleißheim Germany
                [ 7 ] Ministry of Climate Protection, Environment, Energy and Mobility Mainz Germany
                Author notes
                [*] [* ] Correspondence

                Kerstin Wernike and Martin Beer, Friedrich‐Loeffler‐Institut, Greifswald–Insel Riems, Germany.

                Email: kerstin.wernike@ 123456fli.de ; martin.beer@ 123456fli.de

                Author information
                https://orcid.org/0000-0001-8071-0827
                Article
                TBED14600
                10.1111/tbed.14600
                9348064
                35585653
                4bfb5775-63f1-4027-83ac-56b36968b7de
                © 2022 The Authors. Transboundary and Emerging Diseases published by Wiley‐VCH GmbH.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 13 May 2022
                : 04 March 2022
                : 15 May 2022
                Page count
                Figures: 3, Tables: 0, Pages: 8, Words: 5887
                Funding
                Funded by: German Federal Ministry of Food and Agriculture (BMEL)
                Funded by: BMEL through the Federal Office for Agriculture and Food (BLE)
                Funded by: European Union Horizon 2020 project ‘European Virus Archive goes global’ (EVAg)
                Funded by: Animal Disease Funds (Tierseuchenkassen) of the German federal states Lower Saxony, Thuringia, Hesse, Rhineland‐Palatinate, North Rhine‐Westphalia and the Ministry of Energy, Agriculture, the Environment, Nature and Digitalization of the German federal state Schleswig‐Holstein
                Categories
                Short Communication
                Short Communication
                Custom metadata
                2.0
                corrected-proof
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.1.7 mode:remove_FC converted:03.08.2022

                Infectious disease & Microbiology
                bluetongue disease,covid‐19,deer,pestivirus,serology,wildlife
                Infectious disease & Microbiology
                bluetongue disease, covid‐19, deer, pestivirus, serology, wildlife

                Comments

                Comment on this article